Factor VII

Factor VII used to treat bleeding problems in patients with haemophilia type A or B.


Brands
Adult Dose
Dose: 270 mcg/kg
Single Dose: 270 (270)
Frequency: As recommended.
Route: IV
Instructions: To treat hemarthroses:
Neonatal
Paedriatic
Characteristics
Factor VII also known as Proconvertin. . It is of Natural origin and belongs to Amino acid. . It is weakly acidic drug, 240.00% solution of the drug is isotonic.
Contraindications
Factor VII is contraindicated in conditions like Septicaemia,Atherosclerosis,Hypersensitivity to the drug.
Effects
Factor VII produces potentially life-threatening effects which include Anaphylaxis. which are responsible for the discontinuation of Factor VII therapy.The symptomatic adverse reactions produced by Factor VII are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Fever, Diaphoresis.
Indications
'Factor VII is primarily indicated in conditions like Haemophilia, Von willebrand''s disease.'
Interactions
No data regarding the interactions of Factor VII was found.
Interfrence
Risks
Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Powder Store in refrigerator. Do not Freeze. Protect from Sunlight.
Warnings
It should be used only if clearly needed during pregnancy.It should be used with cauiton in patients with any pre-existing diseases or any allergies. Before and during injection check heart rate.The dose or rate of infusion may need to be changed if heart rate is too fast.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.